• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SNT 2.67% 7.3¢

SYNTARA LIMITED

Syntara Limited is an Australia-based clinical-stage drug development company. The... Syntara Limited is an Australia-based clinical-stage drug development company. The Company is targeting extracellular matrix dysfunction with its amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The Company’s lead candidate SNT-5505 is for the bone marrow cancer myelofibrosis which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The Company is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its product candidate, SNT-4728, is an inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis and cardiac fibrosis.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
SNT
SNT-4728 Parkinson’s Disease
11:27 37 14K
11:27 Last post  Rorbag Comments Created with Sketch.  37  Views Created with Sketch.  14K 
SNT
Syntara the science explained
3 4 5
11/02/25 242 93K
11/02/25 Last post  Aremac Comments Created with Sketch.  242  Views Created with Sketch.  93K 
SNT 06/02/25 1 619
Metals & Mining SECTOR NEWS

Apollo Minerals to raise $2m for Salanie Gold Project, championed by drilling contractors

AON
12 Feb 2025
APOLLO MINERALS LIMITED
06/02/25 Last post  ASX News Comments Created with Sketch.  1  Views Created with Sketch.  619 
SNT 06/02/25 11 3.3K
06/02/25 Last post  NZ Trader Comments Created with Sketch.  11  Views Created with Sketch.  3.3K 
SNT
Chart
2
05/02/25 69 34K
05/02/25 Last post  NZ Trader Comments Created with Sketch.  69  Views Created with Sketch.  34K 
SNT 03/02/25 26 7.5K
03/02/25 Last post  ContangoPhil Comments Created with Sketch.  26  Views Created with Sketch.  7.5K 
SNT 29/01/25 1 636
29/01/25 Last post  NZ Trader Comments Created with Sketch.  1  Views Created with Sketch.  636 
SNT
SNT - Media thread
2
26/01/25 75 34K
26/01/25 Last post  Ressy Comments Created with Sketch.  75  Views Created with Sketch.  34K 

See All Discussions arrow Created with Sketch.

Timeline

Company Secretary Appointment/Resignation
06 Feb 18:05
 
Investor Presentation Euroz Hartleys Healthcare Forum
04 Feb 10:04
 
Quarterly Shareholder Report
29 Jan 08:53
 
Quarterly Appendix 4C Cash Flow Report
29 Jan 08:41
 
Application for quotation of securities - SNT
22 Jan 08:28
 
Notice of General Meeting/Proxy Form
17 Jan 10:09
 
View More arrow Created with Sketch.
(20min delay)
Last
7.3¢
Change
-0.002(2.67%)
Mkt cap ! $115.2M
Open High Low Value Volume
7.5¢ 7.5¢ 7.3¢ $79.65K 1.083M

Buyers (Bids)

No. Vol. Price($)
5 512804 7.3¢
 

Sellers (Offers)

Price($) Vol. No.
7.4¢ 126073 7
View Market Depth
Last trade - 12.56pm 12/02/2025 (20 minute delay) ?
Last
7.4¢
  Change
-0.002 ( 1.33 %)
Open High Low Volume
7.4¢ 7.4¢ 7.3¢ 194998
Last updated 13.13pm 12/02/2025 ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.